LexaGene is a biotechnology company developing automated and sensitive instrumentation for rapid pathogen detection.
Our breakthrough technology will transform how pathogens are detected and deliver results in about an hour.
6 July 2017 – LexaGene is pleased to report that the technology for its automated pathogen detection instrument has been successfully de-risked, and an unveiling scheduled.
Innovation in the Making
Imagine a new way of testing on site for multiple pathogens that uses customized genetic screening, doesn’t requite a skilled technician,
and returns results in just one hour. See what’s new with LexaGene and how we are changing the future of pathogen detection.
Introducing the LX6
At a recent conference, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market.
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest, and return results in about an hour.
‘Big Bet’ of 2017
LexaGene declared one of the companies to watch by Pinnacle Digest – a financial newsletter dedicated to bringing its readers insight ‘before the street’ on small cap companies of note.
Food industry news site Food Quality News featured LexaGene in a recent article, interviewing Dr. Jack Regan about the expected applications of the technology in the food processing market and beyond.